Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2; no visible changes to the Study Details page content in the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedRemoval of the government funding status notice/banner from the page. All study details and content remain unchanged.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant changes detected between the old and new screenshots; the page content remains the same, including the study title, brief summary, eligibility criteria, and listed locations for NCT03371979. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange Detected- Added a government-operating-status notice and linked details (cc.nih.gov, opm.gov). - Updated version to v3.2.0. - Removed the resource entry for Genetic and Rare Diseases Information Center: Small cell lung carcinoma and the older v3.1.0 version tag.SummaryDifference4%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element has been removed.SummaryDifference0.2%

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.